SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-17-013269
Filing Date
2017-12-15
Accepted
2017-12-14 21:48:17
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO FORM S-1 fs12017a3_akersbiosciences.htm S-1/A 6090237
2 FORM OF UNDERWRITING AGREEMENT fs12017a3_ex1-1akersbio.htm EX-1.1 301373
3 FORM OF AMENDMENT TO CERTIFICATE OF INCORPORATION, CERTIFICATE OF SERIES B PREFE fs12017a3_ex3-7akersbio.htm EX-3.7 96454
4 FORM OF UNDERWRITER'S WARRANT fs12017a3_ex4-1akersbio.htm EX-4.1 115891
5 OPINION OF LUCOSKY BROOKMAN LLP fs12017a3_ex5-1akersbio.htm EX-5.1 15486
6 CONSENT OF MORISON COGEN LLP, DATED DECEMBER 14, 2017 fs12017a3_ex23-1akersbio.htm EX-23.1 2146
7 GRAPHIC ex5-1_001.jpg GRAPHIC 39544
8 GRAPHIC ex5-1_002.jpg GRAPHIC 9609
9 GRAPHIC image001.jpg GRAPHIC 21467
10 GRAPHIC image002.jpg GRAPHIC 445960
  Complete submission text file 0001213900-17-013269.txt   7334696
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-221746 | Film No.: 171257514
SIC: 2835 In Vitro & In Vivo Diagnostic Substances